New‐onset autoimmune phenomena post‐COVID‐19 vaccination
Y Chen, Z Xu, P Wang, XM Li, ZW Shuai, DQ Ye… - …, 2022 - Wiley Online Library
Abstract Coronavirus disease 2019 (COVID‐19) pandemic caused by severe acute
respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has led to an unprecedented setback for …
respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has led to an unprecedented setback for …
COVID-19 and the clinical course of rheumatic manifestations
The manifestations of COVID-19 have been evolving over time. Various post-COVID-19
syndromes are being recognised. Various viruses have been implicated in the pathogenesis …
syndromes are being recognised. Various viruses have been implicated in the pathogenesis …
Lung epithelial and endothelial damage, loss of tissue repair, inhibition of fibrinolysis, and cellular senescence in fatal COVID-19
F D'Agnillo, KA Walters, Y Xiao, ZM Sheng… - Science translational …, 2021 - science.org
Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), is characterized by respiratory distress, multiorgan …
coronavirus 2 (SARS-CoV-2), is characterized by respiratory distress, multiorgan …
ACE2: the molecular doorway to SARS-CoV-2
MM Medina-Enríquez, S Lopez-León… - Cell & bioscience, 2020 - Springer
The angiotensin-converting enzyme 2 (ACE2) is the host functional receptor for the new
virus SARS-CoV-2 causing Coronavirus Disease 2019. ACE2 is expressed in 72 different …
virus SARS-CoV-2 causing Coronavirus Disease 2019. ACE2 is expressed in 72 different …
Outcomes of COVID-19 in patients with rheumatoid arthritis: a multicenter research network study in the United States
Objectives To investigate outcomes of Coronavirus Disease-2019 (COVID-19) in patients
with rheumatoid arthritis (RA) as compared to the general population. Additionally, outcomes …
with rheumatoid arthritis (RA) as compared to the general population. Additionally, outcomes …
Immune responses during COVID-19 infection
C Melenotte, A Silvin, AG Goubet, I Lahmar… - …, 2020 - Taylor & Francis
Over the past 16 years, three coronaviruses (CoVs), severe acute respiratory syndrome CoV
(SARS-CoV) in 2002, Middle East respiratory syndrome CoV (MERS-CoV) in 2012 and …
(SARS-CoV) in 2002, Middle East respiratory syndrome CoV (MERS-CoV) in 2012 and …
Anticoagulation in COVID-19: current concepts and controversies
A Chandra, U Chakraborty, S Ghosh… - Postgraduate Medical …, 2022 - academic.oup.com
Rising incidence of thromboembolism secondary to COVID-19 has become a global
concern, with several surveys reporting increased mortality rates. Thrombogenic potential of …
concern, with several surveys reporting increased mortality rates. Thrombogenic potential of …
Understanding long COVID; mitochondrial health and adaptation—old pathways, new problems
Many people infected with the SARS-CoV-2 suffer long-term symptoms, such as “brain fog”,
fatigue and clotting problems. Explanations for “long COVID” include immune imbalance …
fatigue and clotting problems. Explanations for “long COVID” include immune imbalance …
COVID-19 and thrombotic microangiopathies
Severe COVID-19 can manifest as multiorgan dysfunction with pulmonary involvement
being the most common and prominent. As more reports emerge in the literature, it appears …
being the most common and prominent. As more reports emerge in the literature, it appears …
[HTML][HTML] Sustained inflammation, coagulation activation and elevated endothelin-1 levels without macrovascular dysfunction at 3 months after COVID-19
Introduction Endothelial damage and thrombosis caused by COVID-19 may imperil
cardiovascular health. More than a year since the WHO declared COVID-19 pandemic …
cardiovascular health. More than a year since the WHO declared COVID-19 pandemic …